- Report
- March 2024
- 200 Pages
Global
From €3669EUR$4,150USD£3,168GBP
- Report
- October 2023
- 145 Pages
Global
From €2785EUR$3,150USD£2,404GBP
- Report
- November 2023
- 181 Pages
Global
From €3979EUR$4,500USD£3,435GBP
- Report
- October 2023
- 190 Pages
Global
From €3979EUR$4,500USD£3,435GBP
- Report
- June 2024
- 206 Pages
Global
From €7029EUR$7,950USD£6,068GBP
- Report
- November 2023
- 224 Pages
Global
From €6631EUR$7,500USD£5,725GBP
- Report
- November 2023
- 115 Pages
United States
From €3316EUR$3,750USD£2,862GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €2431EUR$2,750USD£2,099GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €2431EUR$2,750USD£2,099GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €2431EUR$2,750USD£2,099GBP
- Report
- July 2022
- 196 Pages
Global
From €6631EUR$7,500USD£5,725GBP
- Report
- January 2022
- 200 Pages
Global
From €6631EUR$7,500USD£5,725GBP
- Report
- April 2023
- 114 Pages
Global
From €4200EUR$4,750USD£3,626GBP
- Report
- February 2023
- 135 Pages
Africa
From €2652EUR$3,000USD£2,290GBP
€3316EUR$3,750USD£2,862GBP
- Report
- October 2022
- 74 Pages
Indonesia
From €2370EUR$2,680USD£2,046GBP
€2962EUR$3,350USD£2,557GBP
- Report
- September 2022
- 77 Pages
Canada
From €2370EUR$2,680USD£2,046GBP
€2962EUR$3,350USD£2,557GBP
- Report
- April 2023
- 160 Pages
Global
From €4376EUR$4,949USD£3,778GBP
- Report
- April 2023
- 160 Pages
Global
From €4376EUR$4,949USD£3,778GBP
- Report
- July 2024
- 200 Pages
Global
From €4376EUR$4,949USD£3,778GBP
- Report
- February 2024
- 25 Pages
Global
€15163EUR$17,150USD£13,091GBP

Methotrexate is a drug used to treat immune disorders, such as rheumatoid arthritis, psoriasis, and Crohn's disease. It works by blocking the action of an enzyme involved in the production of certain proteins that are necessary for the growth and development of cells. It is also used to treat certain types of cancer. Methotrexate is available in both oral and injectable forms.
Methotrexate is a widely used drug in the treatment of immune disorders. It is generally well tolerated and has been shown to be effective in reducing symptoms and improving quality of life. It is also used in combination with other drugs to treat more severe cases of immune disorders.
The market for Methotrexate is highly competitive, with many companies offering different formulations of the drug. Some of the major players in the market include Pfizer, Merck, Novartis, and AbbVie. Show Less Read more